I-Mab Biopharma
IMAB
#9469
Rank
$55.42 M
Marketcap
$0.68
Share price
-6.87%
Change (1 day)
-62.84%
Change (1 year)

I-Mab Biopharma (IMAB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : $14.79 Million USD

According to I-Mab Biopharma's latest financial reports the company's total liabilities are $14.79 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

I-Mab Biopharma - Total liabilities on balance sheet (from 2024 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-12-31$17.85 M-26.98%
2022-12-31$24.45 M-4.63%
2021-12-31$25.64 M54.65%
2020-12-31$16.58 M-78.51%
2019-12-31$77.17 M9.61%
2018-12-31$70.41 M125.68%
2017-12-31$31.19 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$12.15 M-17.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.83 B 5,540.68%๐Ÿ‡บ๐Ÿ‡ธ USA